Low patient numbers, an incomplete understanding of the disease pathology, phenotypic heterogeneity and a lack of established endpoints are barriers to efficient and effective clinical trials.
TORONTO (PRWEB) November 07, 2022
Co-creation with patients is vital for effective clinical trial design. A study by Skovlund, PC, Nielsen, BK, Thaysen, HV et al. shows that, in clinical trials, “patient involvement can lead to improvements in design, selection of relevant outcome measures and effective recruitment of trial participants.”
For a medicine to be authorised, clinical efficacy and safety need to be established, usually through robust and relevant clinical trial data. There are several unique challenges in the development of orphan disease treatments. Low patient numbers, an incomplete understanding of the disease pathology, phenotypic heterogeneity and a lack of established endpoints are barriers to efficient and effective clinical trials.
A key aspect is the choice and selection of the primary and key secondary efficacy endpoints: a reliable, valid, sensitive, interpretable and meaningful endpoint is vital to a well-designed study. This is necessary both as the basis to demonstrate the clinical impact of any therapeutic intervention and to stand up to regulatory scrutiny.
In this webinar, attendees will learn how Aparito’s Patient Group Accelerator Programme enables patients to co-create alongside sponsors & CROs. The Accelerator is designed to understand and fulfil patients’ needs by working closely with patient organisations and finding new endpoints that are relevant to their specific conditions.
The featured speakers speak to a young patient to gain their perspective on being involved with clinical trial design and they demonstrate how this feedback can be taken into study design as they close out the session with a real-life example from Aparito’s Accelerator programme.
Register to learn the value of patient co-creation in clinical trial design and how patient involvement can improve trial design and clinical outcome measures.
Join Begonya Nafría, Patients Engagement in Research Coordinator, Sant Joan de Déu Children's Hospital Barcelona; Nora Navarro, Patient, Kids Barcelona; Lucy Dixon, Chair, PCD Support UK; and Elisa Ferrer Mallol, Patient Advocacy Manager, Aparito, for the live webinar on Wednesday, November 23, 2022, at 10am EST (4pm CET/EU-Central).
For more information, or to register for this event, visit The Value of Patient Co-Creation in Clinical Trial Design.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Tel: +1 (416) 977-6555 x371